baber/WOPTO huggingface dataset:
Patent NZ-595116-A (NZ)
Title: Use of rosuvastatin lactols as medicaments
Inventor: LINDSAY DEREK
IPC: A61P9/00
Filed: 2010-03-10
Abstract: 595116 Disclosed herein is the use of a compound of Formula I, wherein the variable are defined in the specification, for the treatment of a condition treatable by the inhibition of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) wherein the considition is selected from the group consisting of hypercholesterolemia, atherosclerosis, hyperlipidemia, cardiovascular disease, coronary heart disease, myocardial infarction, stroke, peripheral artery disease, inflammation, dementia, cancer, nuclear cataracts, diabetes and hypertension.
Patent NZ-603705-A (NZ)
Title: Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
Inventor: HUVAL CHAD
IPC: A61L29/16
Filed: 2011-06-09
Abstract: Disclosed herein is a method for preparing and resulting articles of manufacture comprising a substrate having a surface, a bulk beneath the surface, and a grafted polymer layer on the substrate surface, the substrate surface and the grafted polymer layer, in combination, constituting a modified surface having a fibrinogen adsorption of less than about 125 ng/cm2 in a fibrinogen binding assay in which the modified surface is incubated for 60 minutes at 37 C in 70 µg/mL fibrinogen derived from human plasma containing 1.4 µg/mL I-125 radiolabeled fibrinogen.
Patent NZ-615432-A (NZ)
Title: In-bed solids control valve
Inventor: MARYAMCHIK MIKHAIL
IPC: F27B15/18
Filed: 2010-09-29
Abstract: A circulating fluidized bed (CFB) boiler comprising a reaction chamber (1) is disclosed. A bubbling fluidized bed (BFB) (4) is contained within an enclosure within the lower portion of the reaction chamber and contains an in-bed heat exchanger (IBHX) (3) that occupies part of the reaction chamber floor. At least one non-mechanical valve (40), which includes an opening, is between the CFB and BFB and an independently controlled fluidizing means located both upstream and downstream of the opening, is used to control the heat transfer to the IBHX by controlling the solids discharge from the BFB to the CFB. The elevation of the bottom of the opening is at or above the elevation of the fluidizing means. A flow control barrier may be located downstream of the opening.
Patent NZ-618691-A (NZ)
Title: Fused benzoxazepinones as ion channel modulators
Inventor: CORKEY BRITTON KENNETH
IPC: C07D498/04
Filed: 2012-06-29
Abstract: The disclosure relates to compounds of formula IA that are sodium channel inhibitors, wherein Q, Cy, R2 – R4, R17, R10, m and n are as described in the specification. The disclosure also relates to their use the treatment of various disease states, including cardiovascular diseases and diabetes. The cardiovascular disease may be atrial and ventricular arrhythmias, heart failure (including congestive heart failure, diastolic heart failure, systolic heart failure, acute heart failure), Prinzmetal’s (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, ischemia, recurrent ischemia, reperfusion injury, myocardial infarction, acute coronary syndrome, peripheral arterial disease, pulmonary hypertension or intermittent claudication. Example compounds include: (S)-3-methyl-4-(pyrimidin-2-ylmethyl)-7-(4-(trifluoromethyl)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-S(2H)-one, (R)-3-methyl-4-(pyrimidin-2-ylmethyl)-7-(4-(trifluoromethyl)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-S(2H)-one, 6-((S-oxo-7-(4-(trifluoromethoxy)phenyl)-2,3-dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)methyl)picolinonitrile, 7-(4-(trifluoromethoxy)phenyl)-4-((6-(trifluoromethyl)pyridin-2-yl)methyl)-3,4-dihydrobenzo[f][I,4]oxazepin-5(2H)-one, 7-(4-(trifluoromethoxy)phenyl)-4-((6-(trifluoromethyl)pyridin-3-yl)methyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one, 4-((6-methylpyridin-2-yl)methyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one, (2R,11aS)-2-amino-7-(4-(trifluoromethyl)phenyl)-2,3,11,11a-tetrahydrobenzo[f]pyrrolo[2,1-c][1,4]oxazepin-5(1H)-one, (R)-2-(2,2-difluoroethyl)-8-(4-(trifluoromethyl)phenyl)-3,4,12,12a-tetrahydro-1Hbenzo[f]pyrazino[2,1-c][1,4]oxazepin-6(2H)-one.
Patent NZ-628918-A (NZ)
Title: Nasal assembly
Inventor: DAVIDSON AARON SAMUEL
IPC: A61M16/06
Filed: 2006-10-13
Abstract: A patient interface for delivering breathable gas to a patient, comprising: a frame; a cushion to communicate with a patient’s airways in use, the cushion being coupled with the frame; a rotatable elbow to connect to an air delivery tube; and a vent portion (300) including a plurality of vent holes (305) ordered in a plurality of rows. The plurality of rows include a center row and a flanking row on each side of the center row. The center row includes one additional hole at one end thereof with respect to each flanking row.
Patent NZ-701499-A (NZ)
Title: Medical headgear
Inventor: BLASZCZYKIEWICZ THOMAS
IPC: A61M16/06
Filed: 2009-05-29
Abstract: A headgear device is disclosed comprising a crown section (524) and a strap section (526). Both sections include a skin-facing fabric layer (512, 502), an outer fabric layer (520, 508) and a foam layer (504, 506, 514, 518) between the fabric layers. The layers are laminated and thermoformed together to retain a desired shape and can include regions of varying height. The headgear has a thermoformed crown section and four strap arm sections which can attach to a sleep apnea face mask.
Patent NZ-701985-A (NZ)
Title: Reflective netting material
Inventor: TOYE JONATHAN DALLAS
IPC: C08K3/22
Filed: 2009-04-16
Abstract: Disclosed is a reflective netting material wherein a monofilament of the netting comprises polyethylene with a white pigment such as calcium carbonate in an amount of about 14%, wherein the netting is a knitted, woven, or non-woven structure, from a synthetic monofilament, yarn, or tape or combination thereof, wherein the pigment is selected to provide the netting which reflects at least 30% solar radiation on average across the UV (wavelength about 280-400 nm), visible (wavelength about 400-700 nm) and very near infrared ( wavelength about 700-800 nm) ranges, and which transmits at least 10% on average of solar radiation across the wavelength range about 800-2500nm, and wherein the netting is for placement in an elevated position above the ground and over fruit- or vegetable-bearing plants, such that it can create a plant environment beneath the material which is favourable for the growth of said plants and/or the development of fruit or vegetables borne by the plants, by virtue of diffusion of incident radiation including UV radiation by the netting material. The netting preferably has a cover factor (as herein defined) of less than 90%.
Patent NZ-706218-A (NZ)
Title: Pyrazolopyrimidine jak inhibitor compounds and methods
Inventor: MAGNUSON STEVEN R
IPC: C07D487/04
Filed: 2010-07-02
Abstract: Disclosed are pyrazolopyrimidine compounds of formula (I) and methods for their preparation. The compounds of formula (I) are Janus kinase (JAK) inhibitors, and useful for treating cancer, polycythaemia Vera, essential thrombocytosis, myelofibrosis, chronic myelogenous leukaemia (CML), rheumatoid arthritis, inflammatory bowel syndrome, Chron’s disease, psoriasis, contact dermatitis or delayed hypersensitivity reactions.
Patent NZ-710872-A (NZ)
Title: Substituted 2-azabicycles and their use as orexin receptor modulators
Inventor: GELIN CHRISTINE F
IPC: C07D519/00
Filed: 2014-03-12
Abstract: The present invention is directed to compounds of Formula I: wherein X is N or CR1; Y is N or CR2; R1 is H, alkoxy, halo, triazolyl, pyrimidinyl, oxazolyl, isoxazole, oxadiazolyl, or pyrazolyl; R2 is H, alkyl, alkoxy, or halo; Z is NH or O; R3 is H, alkyl, alkoxy, halo, or triazolyl; R4 is H or alkyl; or R3 and R4, together with the atoms to which they are attached, form a 6- membered aryl ring or a 5- or 6-membered heteroaryl ring; R5 is pyridyl, pyrazinyl, or pyrimidinyl, wherein the pyridyl, pyrazinyl, or pyrimidinyl is optionally substituted with halo or alkyl; and n is 1 or 2. Methods of making the compounds of Formula I are also described. The invention also relates to pharmaceutical compositions comprising compounds of Formula I. Methods of using the compounds of the invention are also within the scope of the invention.
Patent NZ-721987-A (NZ)
Title: Additive mixture for addition to a building material covering mixture and composite covering system formed therefrom
Inventor: HAUSER KASPAR
IPC: C04B40/00
Filed: 2014-11-28
Abstract: The invention relates to an additive mixture for addition to a building material covering mixture for forming a composite covering system for the floor, wall, or facade area, which additive mixture reduces the thermal conductivity or thermal dissipation of covering systems, in particular the thermal dissipation through objects and sub-bases coated with the covering system, in such a way that walking on the sub-base provided with the covering system is no longer associated with a sensation of cold feet. This is achieved in that the additive mixture has a proportion of between 50 %wt and 95 %wt of Muscovite mica.
Patent NZ-727251-A (NZ)
Title: Novel polymorphic form of n-[2-(6-fluoro-1h-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine hydrochloride for the treatment of alzheimer’s
Inventor: DE DIEGO HEIDI LOPEZ
IPC: C07D209/14
Filed: 2015-07-03
Abstract: The present invention relates to a novel polymorphic form of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine hydrochloride (polymorphic form III). The present invention describes the methods of synthesizing polymorphic form III, its use in pharmaceutical compositions and medicaments, and its use as an adjunctive therapy to acetylcholinesterase treatment for the treatment of Alzheimer’s disease.
Patent NZ-742216-A (NZ)
Title: Induction of immune tolerance by using methotrexate
Inventor: JOSEPH ALEXANDRA
IPC: A61K31/519
Filed: 2012-05-03
Abstract: Disclosed is the use of methotrexate in the preparation of a medicament for treating a subject in need of protein replacement therapy, wherein methotrexate reduces undesired immune responses, such as anti- drug antibody (ADA) responses and other T- and/or B-cell-mediated immune responses.
Patent NZ-745597-A (NZ)
Title: Intelligent monitoring systems for liquid electrolyte batteries
Inventor: Herrema Mark
IPC: H01M10/48
Filed: 2016-12-28
Abstract: An improved battery monitoring system for liquid electrolyte batteries is provided. The battery monitoring system includes a network of sensors for monitoring the condition or performance of a plurality of liquid electrolyte batteries, for example lead-acid batteries. The sensors are adapted to share data regarding battery condition or battery performance to a standalone device over a wireless local area network. A server in electrical communication with the standalone device receives some or all of the data for analysis, which can result in maintenance alerts and other alerts being sent to the standalone device. The improved battery monitoring system can reduce or eliminate the manual inspection of lead-acid batteries and can improve battery operation and longevity by ensuring an appropriate level of maintenance for each lead-acid battery.
Patent NZ-747094-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C10G32/04
Filed: 2013-10-10
Abstract: Methods and systems are described for processing cellulosic and lignocellulosic materials into useful intermediates and products, such as energy and fuels. For example, conveying systems, such as highly efficient vibratory conveyors, are described for the processing of the cellulosic and lignocellulosic materials. Provided herein is an apparatus for producing a treated biomass material, that includes an ionizing radiation source. Biomass is conveyed upon a vibratory conveyor having a cooled portion configured to cool the material during exposure to the ionising radiation, wherein at least a portion of the conveyor comprises an enclosure, and wherein the at least a portion of the enclosed conveyor is purged with an inert gas to maintain an atmosphere at a reduced oxygen level.
Patent NZ-753937-A (NZ)
Title: An automobile sunshade panel
Inventor: JIALI CHEN
IPC: B60J7/00
Filed: 2019-05-27
Abstract: This invention discloses an automobile sunshade panel, including a mounting plate 10. When in use, a second connecting casing 29 are pulled to unfold a sun shield 27, and then a second rotary knob 28 is rotated to enable a second chuck 30 being absorbed on a windshield; when not being used, a tightening rotary knob 21 is rotated to pull a pulling wire 31 and the second connecting casing 29, so that the sun shield 27 is pushed to be received together. Furthermore, the sun shield can be directly and fixedly mounted on a top of a automobile, which is not only being used conveniently at any time, but also reduce the time wasting and a complicated installation procedure; moreover, the sun shield can be folded to reduce an occupied area, which is easy to restore and convenient to change.
Patent NZ-760155-A (NZ)
Title: 15.beta.-[3-propanamido]-substituted estra-1,3,5
Inventor: HIRVELÄ LEENA
IPC: C07J43/00
Filed: 2018-06-07
Abstract: The invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof wherein Rl to R4 are as defined in the claims. The invention further relates to their use as inhibitors of 17β-HSD1 and in treatment or prevention of steroid hormone dependent diseases or disorders, such as steroid hormone dependent diseases or disorders requiring the inhibition of the 17β-HSD1 enzyme and/or requiring the lowering of the endogenous estradiol concentration. The present invention also relates to the compounds of formula (II) which defines the 17-ketone compounds corresponding to the 17- oximes of formula (I). The present invention further relates to the preparation of the aforementioned compounds and to pharmaceutical compositions comprising as an active ingredient(s) one or more of the aforementioned compounds or pharmaceutically acceptable salts thereof.
Patent PT-103216-A (PT)
Inventor: MENDES ZITA MARIA DE MOURO VAZ
IPC: C07C303/44
Filed: 2004-12-06
Abstract: A process for producing tamsulosin of formula I and pharmaceutically acceptable addition salts, thereof comprises the steps of: a) Reacting compound R,R-[2-(4-methoxy-phenyl)-1-methyl-ethyl]-(1-phenyl-ethyl)-amine of formula II or a salt thereof  with chlorosulfonic acid with or without an organic solvent, to obtain compound R,R-2-methoxy-5-[2-(1-phenyl-ethylamino)-propyl]-benzenesulfonic acid of formula III b) Hydrogenolysis of compound R,R-2-methoxy-5-[2-(1-phenyl-ethylamino)-propyl]-benzenesulfonic acid of formula III or a salt thereof carried out in an alcohol in the presence of a palladium catalyst using hydrogen or a source of hydrogen, to obtain compound R-(−)-5-(2-amino-propyl)-2-methoxy-benzenesulfonic acid of formula IV c) Reacting primary amine R-(−)-5-(2-amino-propyl)-2-methoxy-benzenesulfonic acid of formula IV, or a salt thereof, with a compound of formula V  wherein X represents an halogen atom selected from the group consisting of Cl; Br and I, to obtain 5-{(2R)-2-[2-(2-ethoxy-phenoxy)-ethylamino]-propyl}-2-methoxy-benzenesulfonic acid compound of formula VI d) Reacting compound of formula VI with an halogenating agent, to obtain the corresponding sulfonylchloride of formula VII. e) Reacting compound VII with ammonia to obtain compound I.
Patent PT-103284-A (PT)
Title: Circuito contador de frequência do tipo endereçamento
Inventor: TANG DI
IPC: H03K21/38
Filed: 2005-06-03
Abstract: É DESCRITO UM CIRCUITO CONTADOR DE FREQUÊNCIA DO TIPO ENDEREÇAMENTO, QUE RECEBE UM PARÂMETRO MÚLTIPLO E UM RELÓGIO DE INSERÇÃO DE ENDEREÇAMENTO DE UM CIRCUITO EXTERNO E UTILIZA ENDEREÇO DE HARDWARE PARA REALIZAR A OPERAÇÃO DE ENDEREÇAMENTO PARA PRODUZIR UM VALOR DE RELÓGIO, DESTE MODO, UTILIZANDO A MEMÓRIA DE FORMA MAIS EFICIENTE, REDUZINDO OS CUSTOS ADQUIRINDO MENOS MEMÓRIA PARA CONSEGUIR O MESMO DESEMPENHO E MELHORANDO A INTEGRAÇÃO DO CIRCUITO CONTADOR DE FREQUÊNCIA DO TIPO ENDEREÇAMENTO.
Patent PT-105599-A (PT)
Title: Cápsula incluindo elemento de actuação, método e dispositivo de processamento desta cápsula
Inventor: NABEIRO RUI MIGUEL
IPC: A47J31/40
Filed: 2011-03-30
Abstract: A PRESENTE INVENÇÃO REFERE-SE A UMA CÁPSULA (1) UTILIZADA NA PRODUÇÃO DE UMA BEBIDA, INCLUINDO UM ELEMENTO DE ATUAÇÃO (5E, 5S) QUE CONFIGURA A SECÇÃO DE PASSAGEM (S2) E CONTROLA OS INSTANTES DA ENTRADA E SAÍDA DE UM ESCOAMENTO (S1, S3) SOB PRESSÃO ATRAVÉS DA CÁPSULA (1). EM PARTICULAR, ESTE ELEMENTO DE ATUAÇÃO (5E, 5S) É PREVIAMENTE CONFIGURADO E DIMENSIONADO E/OU É ACIONADO DE TAL FORMA POR UM RESPETIVO DISPOSITIVO DE EXTRAÇÃO, QUE REALIZA UM DETERMINADO DESLOCAMENTO EM RESULTADO DA APLICAÇÃO DE UMA FORÇA DE ATUAÇÃO (F1, F2) DE NATUREZA MECÂNICA E/OU HIDRÁULICA. UM TAL DIMENSIONAMENTO DO ELEMENTO DE ATUAÇÃO (5E, 5S) E, POR CONSEGUINTE, DA COMBINAÇÃO DE FORÇAS DE ATUAÇÃO (F1, F2) NECESSÁRIAS OU DO MOMENTO DA RESPETIVA APLICAÇÃO, É REALIZADO EM FUNÇÃO DE PARÂMETROS INCLUINDO O TIPO DE SUBSTÂNCIA AROMÁTICA, A DIMENSÃO MÉDIA DO RESPETIVO GRÃO OU O VOLUME DE BEBIDA A OBTER, DE MODO QUE É PROPORCIONADO UM SISTEMA DE CÁPSULAS QUE PERMITE UMA EXTRAÇÃO EFICAZ DE DIFERENTES TIPOS DE BEBIDAS, MEDIANTE VARIAÇÃO APENAS DO RESPETIVO ELEMENTO DE ATUAÇÃO (5E, 5S). A PRESENTE INVENÇÃO REVELA AINDA UM MÉTODO E UM DISPOSITIVO PARA PROCESSAMENTO DA REFERIDA CÁPSULA (1).
Patent RU-94010894-A (RU)
Inventor: MIGEL B ROJO-SAL VADOR
IPC: A61G7/057
Filed: 1994-03-31
Abstract: FIELD: medical equipment. SUBSTANCE: the occipitocervical support features by the fact that it is formed by rectangular prismatic body 1, having central recess 2 in the form of an enlarged softened impression of the occipitocervical section of the patient's vertebral column, positioned on whose both sides are surfaces 3 and 4 for supporting the head when the patient lies on the side. The given support is intended for patients suffering from disturbances in the vertebral column, especially when the patient needs a rest in recumbency with support of the cervical section of the vertebral column in the most physiologic position. EFFECT: enhanced convenience. 3 dwg
Patent RU-94025724-A (RU)
Inventor: KARGAEV L A
IPC: B65D6/24
Filed: 1994-07-11
Abstract: FIELD: storage and shipment of agricultural and industrial products. SUBSTANCE: container has upper and lower frames made from Z-shaped profiles, which are connected by coupling members, removable walls drawn together by flexible member and provided with cross planks. Container has floor and cover, which may be collapsed and placed together with removable walls within upper and lower frames in such a way that much space is saved. Coupling members are made in the form of flexible binder (for instance cable). Corners of upper frame are bent for 45 deg with respect to frame contour to define vertical projections. Corners of lower frame are provided with bevels entering inner cavities of vertical projections of upper frame. Upper cross planks on removable walls mounted on short sides of frames are fixed flush with upper edge of removable walls. EFFECT: improved compactness of assembly, safe storage and shipment of stacked containers, convenient manual detachment of fastening members in the process of loading or unloading of containers.
Patent RU-94028929-A (RU)
Inventor: PETRASH V V
IPC: A61B5/16
Filed: 1994-07-26
Abstract: FIELD: medicine. SUBSTANCE: device has physiological parameters detectors, unit for converting physiologic parameters into feedback signals, unit for indication of feedback signals, provided with vision and hearing images, reproducing playing condition. Device may be used for curing wide range of diseases related to malfunction in physiological functions of cardiovascular system, central and peripheral nervous system and so on. EFFECT: positive motivation of patient when taking procedures.
Patent RU-94040283-A (RU)
Inventor: ZAVALKO A F
IPC: A61K38/16
Filed: 1994-11-01
Abstract: FIELD: medicine, gynecology. SUBSTANCE: method involves administration of hormonal preparations and normalization of immune status. Dalargin is administrated by the following scheme: 0.001 g intramuscularly once per 24 h for 10 days at the II-d phase of menstrual cycle for 3 months, 2 course per year with 6 months interval. Preparation decreases autosensibilization and shows immunostimulating, reparative and antinoceptive effects, prevents immunosuppressive and other by-side effects of hormonal therapy. Dalargin decreases allergological tolerance of many drugs and ensures to avoid polypragmasy. EFFECT: enhanced effectiveness of treatment, decreased relapses and treatment period. 1 cl
Patent RU-94042696-A (RU)
Inventor: SHATROV V F
IPC: A61N5/00
Filed: 1994-11-30
Abstract: FIELD: medical engineering. SUBSTANCE: water for injections contains protium water molecules with special ice- like structure obtained by consecutive freezing demineralized distilled purified water and removing therefrom deiterium water followed by UV light treatment. EFFECT: produced biologically active water.
Patent RU-94045133-A (RU)
Inventor: JOKHANNES JOZEF EHDMUND MARTIN
IPC: F23G5/50
Filed: 1994-12-28
Abstract: FIELD: methods for control of factors having effect on combustion of fuel on fire grate. SUBSTANCE: method consists in recording the three-dimensional distribution of fuel mass in at least one preferable zone of fire grate; to this end, radar measuring device 22 is provided. Device 22 is used together with infrared chamber 23 which gives information on nature of burning-out of fuel on fire grate. According to magnitudes measures with the aid of both devices, control magnitudes may be derived in control unit to have actions on velocity of fire grate, loading device, amount of primary air, composition of primary air, amount of secondary air, composition of secondary air, rotational speed of slag shaft and temperature of air preheater to adjust power of furnace depending on requirements imposed on steam production. EFFECT: improved burning-out of solid particles; positive effect on waste gases from the standpoint of forming of unburnt components of gases and nitric oxides.
Patent RU-94045276-A (RU)
Inventor: MARTIN NUSSBAUM
IPC: B21C23/20
Filed: 1994-01-25
Abstract: FIELD: plastic metal working. SUBSTANCE: method comprises steps of coating round blanks 10 of pure aluminium by soap-base lubricant; pressing out cups 20 from round blanks 10; drawing with thinning cups 20 to initial cups 30 at simultaneously pressing their bottoms in form; cutting initial cans 30; cleaning initial cans 30 by washing them slightly-alkaline water cleaning composition; rinsing them and drying; if it necessary applying inner coat and/or outer print onto cut and cleaned initial cans and also it is necessary reducing and beading cut and cleaned initial cans to ready cans 40. Can 40 has minimum thickness of its wall, bottom and transition zone between wall and bottom selected according to material strength and strength demands to can itself. EFFECT: enhanced efficiency. 1 dwg
Patent RU-95100789-A (RU)
Inventor: FADEEV V A
IPC: A63H33/06
Filed: 1995-01-19
Abstract: FIELD: assembly members, in particular, modelling of three-dimensional bodies such as sets of constructional parts for children. SUBSTANCE: apparatus has plate with channel-shaped slits made on both sides of plate. Channels on one side of plate are made adjacent to one edge and channels on other side are made adjacent to opposite edge of plate. Plate ends are provided with [-shaped slot, which has one wall positioned in plane extending along middle part of plate height and other wall extending in channel bottom plane. Length of [-shaped slot wall positioned in channel bottom plane is less than length of wall positioned in plane extending through middle line of plate height. EFFECT: increased entertainment effect and provision for acquiring a habit in constructing three-dimensional structures. 10 cl, 14 dwg